rs2304052
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003118.4(SPARC):c.66A>G(p.Glu22Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0942 in 1,613,444 control chromosomes in the GnomAD database, including 12,123 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 4106 hom., cov: 32)
Exomes 𝑓: 0.086 ( 8017 hom. )
Consequence
SPARC
NM_003118.4 synonymous
NM_003118.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0140
Genes affected
SPARC (HGNC:11219): (secreted protein acidic and cysteine rich) This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 5-151674666-T-C is Benign according to our data. Variant chr5-151674666-T-C is described in ClinVar as [Benign]. Clinvar id is 1287045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.014 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPARC | NM_003118.4 | c.66A>G | p.Glu22Glu | synonymous_variant | Exon 3 of 10 | ENST00000231061.9 | NP_003109.1 | |
SPARC | NM_001309444.2 | c.66A>G | p.Glu22Glu | synonymous_variant | Exon 3 of 10 | NP_001296373.1 | ||
SPARC | NM_001309443.2 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 3 of 10 | NP_001296372.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.172 AC: 26219AN: 152036Hom.: 4085 Cov.: 32
GnomAD3 genomes
AF:
AC:
26219
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.101 AC: 25390AN: 251106Hom.: 2345 AF XY: 0.0982 AC XY: 13327AN XY: 135696
GnomAD3 exomes
AF:
AC:
25390
AN:
251106
Hom.:
AF XY:
AC XY:
13327
AN XY:
135696
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0861 AC: 125767AN: 1461290Hom.: 8017 Cov.: 31 AF XY: 0.0871 AC XY: 63302AN XY: 726944
GnomAD4 exome
AF:
AC:
125767
AN:
1461290
Hom.:
Cov.:
31
AF XY:
AC XY:
63302
AN XY:
726944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.173 AC: 26281AN: 152154Hom.: 4106 Cov.: 32 AF XY: 0.171 AC XY: 12719AN XY: 74378
GnomAD4 genome
AF:
AC:
26281
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
12719
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
400
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 20, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Osteogenesis imperfecta type 17 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at